Skip to content

Allogeneic Platelet-Rich Plasma Versus Corticosteroid Injection for the Treatment of lateral epicondylitis: a prospective, randomized, controlled study

Allogeneic Platelet-Rich Plasma Versus Corticosteroid Injection for the Treatment of lateral epicondylitis: a prospective, randomized, controlled study

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2300076812
Enrollment
Unknown
Registered
2023-10-19
Start date
2023-10-20
Completion date
Unknown
Last updated
2023-10-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Lateral Epicondylitis

Interventions

Allogeneic PRP group:Injection of PRP in lateral epicondyle
Corticosteroid group:Injection of corticosteroid in lateral epicondyle

Sponsors

The First Affiliated Hospital of Soochow University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 60 Years

Inclusion criteria

Inclusion criteria: (1)age between 18 and 60 years (2)patients with suggestive symptoms of lateral epicondylitis (point tenderness, decreased grip strength and pain with resisted wrist extension)(3)at least 6 months of duration and unresponsive to a course of conservative treatment including non-steroidal anti-inflammatory drugs,physical therapy modalities, and splints;(4)ability to provide informed consent.

Exclusion criteria

Exclusion criteria: (1)recalcitrant cases (greater than 18 months of pain prior to treatment);(2)prior elbow surgery or history of elbow trauma;(3)invasive treatment within 3 months before study enrollment;(4)patients with inflammatory arthritis or uncontrolled diabetes (patients whose serum glucose levels are under control with oral antidiabetic drugs and not higher than 150 mg/mL);(5)systemic disorders such as rheumatoid arthritis, diabetes, osteoporosis,immunodeficiencies, or infections(6)neck pain;(7)shoulder pain on the ipsilateral side;(8)other chronic widespread pain syndromes

Design outcomes

Primary

MeasureTime frame
the Disabilities of the Arm, Shoulder and Hand (DASH) outcome measure;VAS;

Secondary

MeasureTime frame
pain-free grip strength (PFG) ;Pressure Pain Threshold (PPT);

Countries

China

Contacts

Public ContactGuo Jiong-Jiong

The First Affiliated Hospital of Soochow University

drjjguo@163.com+86 180 1356 3327

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026